Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

PRINCIPLE trial

- PMLiVE

Russia’s COVID-19 vaccine demonstrates early potential in Lancet report

However, there is too little data to definitively confirm efficacy

- PMLiVE

Gavi says 76 wealthy countries have committed to COVAX vaccine facility

Countries have signed intent to joining COVID-19 vaccine initiative

Leveraging Data, Technology & Expertise to Solve Problems & Transform Healthcare

Tushar Pant, Consulting Executive in Healthcare at IBM, discusses how technology is transforming healthcare. Among many other things, we explore how IBM is working to improve the healthcare industry in Canada,...

Impetus Digital

- PMLiVE

Standard steroid improves recovery of critically-ill COVID-19 patients

The study evaluated hydrocortisone in 403 patients with suspected or confirmed COVID-19

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Research Partnership

Roche Basel Switzerland

Roche plans to launch rapid COVID-19 antigen test later this month

Swiss pharma also intends to file for emergency approval in the US

Article: Why pharma must trust the science of behaviour

In a recent interview with PME Magazine, Dan Coffin, Director explains why the application of behavioural science will be key to better health far beyond COVID-19.Read the full article here:...

Research Partnership

EU flag

EU to contribute €400m to WHO’s COVID-19 vaccine facility

Contribution will go towards ensuring equitable access to COVID-19 vaccines

- PMLiVE

American Medical Association calls for COVID-19 vaccine development transparency

Organisation asks FDA to provide transparent information on review plans

- PMLiVE

Novacyt launches diagnostic test to differentiate between COVID-19 and flu

Test launches in time for upcoming winter flu season

- PMLiVE

EU aims to vaccinate 40% of population in initial COVID-19 blueprint

Target is double the goal set by the World Health Organization

- PMLiVE

Novavax CEO anticipates filing COVID-19 vaccine for approval in December

Pfizer also announces over 50% enrolment in COVID-19 vaccine trial

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links